Smiths Falls-based Canopy Growth (TSX:WEED)(NYSE:CGC) announced Tuesday that it’s working with one of the world’s largest researchers to advance new cannabis products and applications.
The local licensed producer will work with Battelle, a Columbus-based company that purports to be the largest private R&D non-profit in the world. The Ohio firm, which reported US$4.8 billion in annual revenues in 2016, has had a hand in notable scientific breakthroughs and product developments throughout history including Xerox copying, cruise control and compact discs.
As part of the two firm’s partnership, Canopy says it went through the rigorous application process to export samples of cannabis to Battelle’s testing facilities in the United States. Taking cannabis across the border between the United States and Canada remains federally illegal, even into states where weed has been legalized.
(Sponsored)
How shared goals at Tamarack Ottawa Race Weekend strengthen workplace culture
Across workplaces of all sizes and sectors, organizations are continuing to look for meaningful ways to bring people together. Team connection, employee well-being, and community impact are no longer separate
Borden Ladner Gervais LLP and partners lead with generosity
Borden Ladner Gervais LLP (BLG) are no strangers to supporting charities in the nation’s capital. From the Boys & Girls Club of Ottawa to Crohn’s and Colitis Canada to the
“As more states, including Ohio, approve the use of medical cannabis to help individuals with certain illnesses, we believe that Battelle will be able to apply our rigorous and independent research and analysis to advance knowledge and improve safety in what is essentially uncharted territory,” said Battelle president and CEO Lou Von Thaer in a statement.
